« Back
Home /
PSCA (ready-to-use)

PSCA (ready-to-use)

Item no.	18-272-196279
Manufacturer	GENWAY
Amount	7 ml
Category	Oncology Antibodies Immunohistochemistry Primary Antibodies By Organ Colorectal Cancer
Type	Antibody
Applications	IHC
Specific against	other
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	GWB-205408
Similar products	18-272-196279
Available
Genway ID:	GWB-205408
Isotype:	IgG
Immunogen:	Synthetic peptide (Human) (extracellular).
Antigen Species:	Human
Positive Control:	Bladder carcinoma and Prostate carcinoma
Target:	PSCA
Localization:	Plasma membrane Storage
Buffer:	PBS pH 7. 4 containing 1%BSA and 0. 1% sodium azide
Application Note:	IHC-P: Use at an assay dependent dilution. Perform heat mediated antigen retrieval before commencing with IHC staining protocol. Not tested in other applications. Optimal dilutions/concentrations should be determined by the end user. Cellular
Localization:	Plasma membrane PSCA (Prostate Stem Cell antigen) is a cell surface antigen which is overexpressed in ~40% of primary prostate cancers and in as many as 100% of metastatic ones. PSCA is also overexpressed in a majority of transitional cell and pancreatic carcinomas. Antibody directed against PSCA inhibits tumorigenesis slows tumor growth prolongs survival and prevents metastasis in a preclinical zenograft model indicating that PSCA may have utility as a prognostic marker and/or therapeutic target in prostate cancer.
Function:	May be involved in the regulation of cell proliferation. Has a cell-proliferation inhibition activity in vitro.
Subcellular Location:	Cell membrane; Lipid-anchor GPI-anchor.
Tissue Specificity:	Highly expressed in prostate (basal secretory and neuroendocrine epithelium cells). Also found in bladder (transitional epithelium) placenta (trophoblasts) stomach (neuroendocrine cells) colon (neuroendocrine cells) and kidney (collecting ducts). Overexpressed in prostate cancers and expression is correlated with tumor stage grade and androgen-independence. Highly expressed in prostate cancer bone metastases. Expressed in gastric epithelial cells mainly in the isthmus (at protein level). Not detected in normal intestinal epithelium (at protein level).
Induction:	Down-regulated in gastric cancer cells.
Polymorphism:	Genetic variations in PSCA may influence susceptibility to diffuse-type gastric cancer.
Similarity:	Contains 1 UPAR/Ly6 domain.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 7 ml

available

Delivery expected until 8/30/2024

Express Delivery: Save 7 days

Compare

Add to wishlist

Recommend by mail